Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Depreciation & Amortization (CF) (2017 - 2021)

Historic Depreciation & Amortization (CF) for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to $68000.0.

  • Cogent Biosciences' Depreciation & Amortization (CF) rose 30000.0% to $68000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $147000.0, marking a year-over-year decrease of 7958.33%. This contributed to the annual value of $2.6 million for FY2025, which is 400.0% up from last year.
  • According to the latest figures from Q4 2021, Cogent Biosciences' Depreciation & Amortization (CF) is $68000.0, which was up 30000.0% from $48000.0 recorded in Q3 2021.
  • In the past 5 years, Cogent Biosciences' Depreciation & Amortization (CF) registered a high of $352000.0 during Q4 2018, and its lowest value of $14000.0 during Q2 2021.
  • In the last 5 years, Cogent Biosciences' Depreciation & Amortization (CF) had a median value of $297500.0 in 2017 and averaged $232600.0.
  • Over the last 5 years, Cogent Biosciences' Depreciation & Amortization (CF) had its largest YoY gain of 30000.0% in 2021, and its largest YoY loss of 9510.49% in 2021.
  • Quarter analysis of 5 years shows Cogent Biosciences' Depreciation & Amortization (CF) stood at $307000.0 in 2017, then grew by 14.66% to $352000.0 in 2018, then decreased by 10.8% to $314000.0 in 2019, then plummeted by 94.59% to $17000.0 in 2020, then soared by 300.0% to $68000.0 in 2021.
  • Its last three reported values are $68000.0 in Q4 2021, $48000.0 for Q3 2021, and $14000.0 during Q2 2021.